Literature DB >> 33961692

Can a Simple Stool Swab Predict Bacteremia in High-Risk Hematopoietic Cell Transplant Recipients?

Steven A Pergam1,2,3, Sanjeet S Dadwal4.   

Abstract

Entities:  

Keywords:  fluoroquinolone; hematopoietic cell transplantation; prophylaxis; resistance; screening

Mesh：

Substances：

Year:  2021        PMID： 33961692      PMCID： PMC8492139          DOI： 10.1093/cid/ciab412

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  7 in total

1.  Better Sepsis Management Rather Than Fluoroquinolone Prophylaxis for Patients With Cancer-Related Immunosuppression.

Authors:  Monica A Slavin; Leon J Worth; John F Seymour; Karin A Thursky
Journal:  J Clin Oncol       Date:  2019-03-07       Impact factor: 44.544

2.  Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.

Authors:  Giampaolo Bucaneve; Alessandra Micozzi; Francesco Menichetti; Pietro Martino; M Stella Dionisi; Giovanni Martinelli; Bernardino Allione; Domenico D'Antonio; Maurizio Buelli; A Maria Nosari; Daniela Cilloni; Eliana Zuffa; Renato Cantaffa; Giorgina Specchia; Sergio Amadori; Francesco Fabbiano; Giorgio Lambertenghi Deliliers; Francesco Lauria; Robin Foà; Albano Del Favero
Journal:  N Engl J Med       Date:  2005-09-08       Impact factor: 91.245

3.  Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipients.

Authors:  M Mikulska; V Del Bono; P Bruzzi; A M Raiola; F Gualandi; M T Van Lint; A Bacigalupo; C Viscoli
Journal:  Infection       Date:  2011-12-21       Impact factor: 3.553

4.  Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis.

Authors:  Roni Shouval; Joshua A Fein; Myriam Labopin; Nicolaus Kröger; Rafael F Duarte; Peter Bader; Christian Chabannon; Jurgen Kuball; Grzegorz Wladyslaw Basak; Carlo Dufour; Jacques-Emmanuel Galimard; Emmanuelle Polge; Arjan Lankester; Silvia Montoto; John A Snowden; Jan Styczynski; Ibrahim Yakoub-Agha; Mohamad Mohty; Arnon Nagler
Journal:  Lancet Haematol       Date:  2019-08-30       Impact factor: 18.959

5.  Fluoroquinolone Prophylaxis Selects for Meropenem-nonsusceptible Pseudomonas aeruginosa in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients.

Authors:  Morgan Hakki; Romney M Humphries; Peera Hemarajata; Gregory B Tallman; Ryan K Shields; Roberta T Mettus; Yohei Doi; James S Lewis
Journal:  Clin Infect Dis       Date:  2019-05-30       Impact factor: 9.079

6.  Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts.

Authors:  George B McDonald; Brenda M Sandmaier; Marco Mielcarek; Mohamed Sorror; Steven A Pergam; Guang-Shing Cheng; Sangeeta Hingorani; Michael Boeckh; Mary D Flowers; Stephanie J Lee; Frederick R Appelbaum; Rainer Storb; Paul J Martin; H Joachim Deeg; Gary Schoch; Ted A Gooley
Journal:  Ann Intern Med       Date:  2020-01-21       Impact factor: 25.391

7.  Colonization With Fluoroquinolone-Resistant Enterobacterales Decreases the Effectiveness of Fluoroquinolone Prophylaxis in Hematopoietic Cell Transplant Recipients.

Authors:  Michael J Satlin; Liang Chen; Claire Douglass; Michael Hovan; Emily Davidson; Rosemary Soave; Marisa La Spina; Alexandra Gomez-Arteaga; Koen van Besien; Sebastian Mayer; Adrienne Phillips; Jing-Mei Hsu; Rianna Malherbe; Catherine B Small; Stephen G Jenkins; Lars F Westblade; Barry N Kreiswirth; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2021-10-05       Impact factor: 20.999
  7 in total
  1 in total

1.  Cessation of Ciprofloxacin Prophylaxis in Hemato-Oncology Patients.

Authors:  Louise Caldwell; Anjaneya Bapat; Lydia N Drumright; Jonathan Lambourne; Fergus G Jimenez-England; James Aries; Lydia Eccersley; Simon Hallam; Silvia Montoto; Heather Oakervee; John Riches; Samir G Agrawal
Journal:  Clin Infect Dis       Date:  2022-08-24       Impact factor: 20.999
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.